Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

PURPOSE: Within breast tissue, aromatase expression and activity is increased by prostaglandin E2, providing a rationale for combining the COX-2 inhibitor celecoxib with an aromatase inhibitor. To evaluate the effect of these drugs on aromatase and other biomarkers, a phase II trial of neoadjuvant e...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lustberg, Maryam B., Povoski, Stephen P., Zhao, Weiqiang, Ziegler, Rebecca M., Sugimoto, Yasuro, Ruppert, Amy S., Lehman, Amy M., Shiels, Donna R., Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Layman, Rachel M., Brueggemeier, Robert W., Shapiro, Charles L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440773/
https://ncbi.nlm.nih.gov/pubmed/21729671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky